“ Evaluation of Soluble PD-1 and PD-L1 in Iraqi Type 2 Diabetes Mellitus (T2DM) Patients with Chronic Toxoplasmosis”, MLU, vol. 20, no. 3, pp. 609–615, Jul. 2020, doi: 10.37506/mlu.v20i3.1467.